FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Andrzej Kudelka

Research Profile

Disorders

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Claire F Verschraegen; Keith Skubitz; Adil Daud; Andrzej P Kudelka; Ian Rabinowitz; Cecilia Allievi; Amy Eisenfeld; jack w singer; Fred B Oldham
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors.
Janet de Moor; Carl A de Moor; Karen Basen-Engquist; Andrzej P Kudelka; Michael W Bevers; Lorenzo Cohen
Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy.
Patricia A Parker; Andrzej P Kudelka; Karen Basen-Engquist; John Kavanagh; Janet de Moor; Lorenzo Cohen
The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Andrzej Kudelka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Claire F Verschraegen; Keith Skubitz; Adil Daud; Andrzej P Kudelka; Ian Rabinowitz; Cecilia Allievi; Amy Eisenfeld; jack w singer; Fred B Oldham
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology 2009;63(5):903-10.
2006: Janet de Moor; Carl A de Moor; Karen Basen-Engquist; Andrzej P Kudelka; Michael W Bevers; Lorenzo Cohen
Optimism, distress, health-related quality of life, and change in cancer antigen 125 among patients with ovarian cancer undergoing chemotherapy.
Psychosomatic medicine 2006;68(4):555-62.
2006: Patricia A Parker; Andrzej P Kudelka; Karen Basen-Engquist; John Kavanagh; Janet de Moor; Lorenzo Cohen
The associations between knowledge, CA125 preoccupation, and distress in women with epithelial ovarian cancer.
Gynecologic oncology 2006;100(3):495-500.
2005: Aleksandra Kraeher; Mohsen S Eledrisi; Steven A Lieberman; Andrzej P Kudelka
Visual vignette.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2005;11(6):412.
2004: Claire F Verschraegen; Andrzej P Kudelka; Wei Hu; Monique Vincent; John J Kavanagh; Evelyne M Loyer; Luc Bastien; A Duggal; Robert L De Jager
A phase II study of intravenous exatecan mesylate (DX-8951f) administered daily for 5 days every 3 weeks to patients with advanced ovarian, tubal or peritoneal cancer resistant to platinum, taxane and topotecan.
Cancer chemotherapy and pharmacology 2004;53(1):1-7.
2003: Wei Hu; WeiGuo Wu; Claire F Verschraegen; Ling Chen; Li Mao; Sai-Ching Jim Yeung; Andrzej P Kudelka; Ralph S Freedman; John J Kavanagh
Proteomic identification of heat shock protein 70 as a candidate target for enhancing apoptosis induced by farnesyl transferase inhibitor.
Proteomics 2003;3(10):1904-11.
2003: Lorenzo Cohen; Walter F Baile; Evelyn Henninger; Sandeep K Agarwal; Andrzej P Kudelka; Renato Lenzi; Janet Sterner; Gailen D Marshall
Physiological and psychological effects of delivering medical news using a simulated physician-patient scenario.
Journal of behavioral medicine 2003;26(5):459-71.
2003: Claire F Verschraegen; Silke Westphalen; Wei Hu; Evelyne M Loyer; Andrzej P Kudelka; Peter Völker; John Kavanagh; Melissa Steger; Klaus-Dieter Schulz; Günter Emons
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.
Gynecologic oncology 2003;90(3):552-9.
2003: Bohuslav Melichar; Renato Lenzi; Michael Rosenblum; Andrzej P Kudelka; John J Kavanagh; Karolina Melicharova; Stacie Templin; Michael E Garcia; James L Abbruzzese; Ralph S Freedman
Intraperitoneal fluid neopterin, nitrate, and tryptophan after regional administration of interleukin-12.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2003;26(3):270-6.
2003: Claire F Verschraegen; Wei Hu; Yu Du; John Mendoza; Janet Early; Michael Deavers; Ralph S Freedman; Robert C Bast; Andrzej P Kudelka; John J Kavanagh; Beppino C Giovanella
Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(2):845-52.
2002: Renato Lenzi; Michael Rosenblum; Claire F Verschraegen; Andrzej P Kudelka; John J Kavanagh; Marshall E Hicks; Eric A Lang; Michael A Nash; Lawrence B Levy; Michael E Garcia; Chris D Platsoucas; James L Abbruzzese; Ralph S Freedman
Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3686-95.
2002: Michael Le Blanc; Jennifer Russo; Andrzej P Kudelka; Judith A Smith
An in vitro study of inhibitory activity of gossypol, a cottonseed extract, in human carcinoma cell lines.
Pharmacological research : the official journal of the Italian Pharmacological Society 2002;46(6):551-5.
2002: James L Murray; Michael E Gillogly; Donna Przepiorka; Hannah Brewer; Nuhad K Ibrahim; Daniel J Booser; Gabriel N Hortobagyi; Andrzej P Kudelka; Kenneth H Grabstein; Martin A Cheever; Constantin G Ioannides
Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2+ patients with metastatic breast and ovarian cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3407-18.
2002: Agapito Castilleja; Darrick Carter; Clay L Efferson; Nancy E Ward; Kouichiro Kawano; Bryan Fisk; Andrzej P Kudelka; David M Gershenson; James L Murray; Catherine A O'Brian; Constantin G Ioannides
Induction of tumor-reactive CTL by C-side chain variants of the CTL epitope HER-2/neu protooncogene (369-377) selected by molecular modeling of the peptide: HLA-A2 complex.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(7):3545-54.
2002: Agapito Castilleja; Nancy E Ward; Richard B Epstein; Andrzej P Kudelka; David M Gershenson; Clay L Efferson; Catherine A O'Brian; Constantin G Ioannides
Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro.
Oncology reports 2002;9(5):929-35.
2002: Wei Hu; Claire F Verschraegen; WG Wu; M Nash; Ralph S Freedman; Andrzej P Kudelka; John J Kavanagh
Activity of ALRT 1550, a new retinoid, with interferon-gamma on ovarian cancer cell lines.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2002;12(2):202-7.
2001: Claire F Verschraegen; John J Kavanagh; Evelyne M Loyer; DC Bodurka-Bevers; Andrzej P Kudelka; W Hu; M Vincent; T Nelson; Charles Levenback
Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
Cancer 2001;92(9):2327-33.
2001: Claire F Verschraegen; M Benjapibal; W Supakarapongkul; Lawrence B Levy; Merrick Ross; E Neely Atkinson; DC Bodurka-Bevers; John J Kavanagh; Andrzej P Kudelka; Sewa S Legha
Vulvar melanoma at the M. D. Anderson Cancer Center: 25 years later.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2001;11(5):359-64.
2001: S Koonsaeng; Claire F Verschraegen; R Freedman; M Bossens; Andrzej P Kudelka; John Kavanagh; T Sittisomwong; E DeClercq; R Snoeck
Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
Journal of medical virology 2001;64(2):195-8.
2001: Patricia A Parker; Walter F Baile; Carl de Moor; Renato Lenzi; Andrzej P Kudelka; Lorenzo Cohen
Breaking bad news about cancer: patients' preferences for communication.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):2049-56.
2001: P Azevedo; Claire F Verschraegen; John J Kavanagh; Andrzej P Kudelka; Ralph S Freedman; K Lu; M T Deavers
Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.
European journal of gynaecological oncology 2001;22(5):319-21.
2001: Agapito Castilleja; Nancy E Ward; Catherine A O'Brian; B Swearingen; Eric A Swan; MA Gillogly; James L Murray; Andrzej P Kudelka; David M Gershenson; Constantin G Ioannides
Accelerated HER-2 degradation enhances ovarian tumor recognition by CTL. Implications for tumor immunogenicity.
Molecular and cellular biochemistry 2001;217(1-2):21-33.
2000: BW Anderson; Andrzej P Kudelka; T Honda; M S Pollack; David M Gershenson; MA Gillogly; James L Murray; Constantin G Ioannides
Induction of determinant spreading and of Th1 responses by in vitro stimulation with HER-2 peptides.
Cancer immunology, immunotherapy : CII 2000;49(9):459-68.
2000: C Moon; Claire F Verschraegen; M Bevers; R Freedman; Andrzej P Kudelka; John J Kavanagh
Use of docetaxel (Taxotere) in patients with paclitaxel (Taxol) hypersensitivity.
Anti-cancer drugs 2000;11(7):565-8.
2000: Claire F Verschraegen; T Sittisomwong; Andrzej P Kudelka; E d Guedes; Melissa Steger; T Nelson-Taylor; Monique Vincent; R Rogers; E Neely Atkinson; John J Kavanagh
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(14):2733-9.
2000: Ralph S Freedman; Andrzej P Kudelka; John J Kavanagh; Claire F Verschraegen; Creighton L Edwards; M Nash; L Levy; E Neely Atkinson; Hua-Zhong Zhang; Bohuslav Melichar; Rebecca Patenia; Stacie Templin; W Scott; Chris D Platsoucas
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2268-78.
2000: Wei Hu; Pierre D McCrea; Michael Deavers; John J Kavanagh; Andrzej P Kudelka; Claire F Verschraegen
Increased expression of fascin, motility associated protein, in cell cultures derived from ovarian cancer and in borderline and carcinomatous ovarian tumors.
Clinical & experimental metastasis 2000;18(1):83-8.
2000: Claire F Verschraegen; Charles Levenback; Monique Vincent; J Wolf; Michael W Bevers; Evelyne M Loyer; Andrzej P Kudelka; John J Kavanagh
Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan.
Annals of the New York Academy of Sciences 2000;922():349-51.
2000: Claire F Verschraegen; Monique Vincent; James L Abbruzzese; D Siegler; John J Kavanagh; Evelyne M Loyer; Andrzej P Kudelka; E Rubin
Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies.
Annals of the New York Academy of Sciences 2000;922():345-8.
2000: T Sittisomwong; A Suneja; Andrzej P Kudelka; Claire F Verschraegen; John J Kavanagh
Estrogen replacement therapy and ovarian cancer.
European journal of gynaecological oncology 2000;21(4):348-54.
2000: Walter F Baile; Robert Buckman; Renato Lenzi; GA Glober; Estela A Beale; Andrzej P Kudelka
SPIKES-A six-step protocol for delivering bad news: application to the patient with cancer.
The oncologist 2000;5(4):302-11.
1999: George E Peoples; BW Anderson; Tom V Lee; James L Murray; Andrzej P Kudelka; J Taylor Wharton; Constantin G Ioannides
Vaccine implications of folate binding protein, a novel cytotoxic T lymphocyte-recognized antigen system in epithelial cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4214-23.
1999: Walter F Baile; Andrzej P Kudelka; Estela A Beale; GA Glober; E G Myers; Anthony Greisinger; Robert C Bast; M G Goldstein; D Novack; Renato Lenzi
Communication skills training in oncology. Description and preliminary outcomes of workshops on breaking bad news and managing patient reactions to illness.
Cancer 1999;86(5):887-97.
1999: D K Kim; Tom V Lee; Agapito Castilleja; BW Anderson; George E Peoples; Andrzej P Kudelka; James L Murray; T Sittisomwong; J Taylor Wharton; J W Kim; Constantin G Ioannides
Folate binding protein peptide 191-199 presented on dendritic cells can stimulate CTL from ovarian and breast cancer patients.
Anticancer research 1999;19(4B):2907-16.
1999: Walter F Baile; GA Glober; Renato Lenzi; Estela A Beale; Andrzej P Kudelka
Discussing disease progression and end-of-life decisions.
Oncology (Williston Park, N.Y.) 1999;13(7):1021-31; discussion 1031-6, 1038.
1999: Michael G Rosenblum; Claire F Verschraegen; James L Murray; Andrzej P Kudelka; Jacalyn B Gano; Lawrence Cheung; John J Kavanagh
Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(5):953-61.
1999: Claire F Verschraegen; E Gupta; Evelyne M Loyer; John J Kavanagh; Andrzej P Kudelka; Ralph S Freedman; Creighton L Edwards; Nick Harris; Melissa Steger; V Steltz; Beppino C Giovanella; John S Stehlin
A phase II clinical and pharmacological study of oral 9-nitrocamptothecin in patients with refractory epithelial ovarian, tubal or peritoneal cancer.
Anti-cancer drugs 1999;10(4):375-83.
1998: B Babcock; BW Anderson; Ioannis Papayannopoulos; Agapito Castilleja; James L Murray; Stefano Stifani; Andrzej P Kudelka; J Taylor Wharton; Constantin G Ioannides
Ovarian and breast cytotoxic T lymphocytes can recognize peptides from the amino enhancer of split protein of the Notch complex.
Molecular immunology 1998;35(17):1121-33.
1998: George E Peoples; BW Anderson; Bryan Fisk; Andrzej P Kudelka; J Taylor Wharton; Constantin G Ioannides
Ovarian cancer-associated lymphocyte recognition of folate binding protein peptides.
Annals of surgical oncology 1998;5(8):743-50.
1998: Zia Rahman; John Kavanagh; Richard Champlin; R Giles; EG Hanania; S Fu; Z Zu; RC Mehra; Frankie A Holmes; Andrzej P Kudelka; David F Claxton; Claire F Verschraegen; James L Gajewski; Michael Andreeff; S Heimfeld; R Berenson; D Ellerson; L Calvert; Eugene Mechetner; Tatyana A Holzmayer; A Dayne; J Hamer; CR Bachier; J Ostrove; Albert Deisseroth
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2717-21.
1998: Andrzej P Kudelka; Renato Lenzi; E Neely Atkinson; Lawrence B Levy; Ralph S Freedman
Is ascitic fluid interleukin-12 an independent prognostic factor in ovarian cancer? The necessity of correction milligram P values for multiple comparisons.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(9):3208-9.
1998: Andrzej P Kudelka; A Vasuratna; Creighton L Edwards; K Augustine; M Benjapibal; Claire F Verschraegen; John J Kavanagh
Gemcitabine after bone marrow transplantation for refractory juvenile granulosa cell tumor.
Anti-cancer drugs 1998;9(7):621-3.
1998: John J Kavanagh; Claire F Verschraegen; Andrzej P Kudelka
Irinotecan in cervical cancer.
Oncology (Williston Park, N.Y.) 1998;12(8 Suppl 6):94-8.
1998: M Benjapibal; Andrzej P Kudelka; A Vasuratna; Creighton L Edwards; Claire F Verschraegen; V Valero; Saroj Vadhan-Raj; John J Kavanagh
Docetaxel and cyclophosphamide induced remission in platinum and paclitaxel refractory ovarian cancer.
Anti-cancer drugs 1998;9(6):577-9.
1998: JM Hudson; Agapito Castilleja; James L Murray; T Honda; Andrzej P Kudelka; Eva Singletary; J Taylor Wharton; Constantin G Ioannides
Growth and antigen recognition of tumor-infiltrating lymphocytes from human breast cancer.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1998;18(7):529-36.
1998: Claire F Verschraegen; A Vasuratna; C Edwards; R Freedman; Andrzej P Kudelka; Carmen Tornos; John J Kavanagh
Clinicopathologic analysis of mullerian adenosarcoma: the M.D. Anderson Cancer Center experience.
Oncology reports 1998;5(4):939-44.
1998: Ralph S Freedman; Renato Lenzi; Andrzej P Kudelka; DD Lawrence; Michael Rosenblum; Chris D Platsoucas
Intraperitoneal immunotherapy of peritoneal carcinomatosis.
Cytokines, cellular & molecular therapy 1998;4(2):121-40.
1998: Andrzej P Kudelka; Annette Hasenburg; Claire F Verschraegen; Creighton L Edwards; Christina A Meyers; D Varma; Ralph S Freedman; Arthur Forman; Charles A Conrad; W Grove; Axel Grothey; John J Kavanagh
Phase II study of i.v. CI-980 in patients with advanced platinum refractory epithelial ovarian carcinoma.
Anti-cancer drugs 1998;9(5):405-9.
1998: Michael A Nash; Renato Lenzi; Creighton L Edwards; John J Kavanagh; Andrzej P Kudelka; Claire F Verschraegen; Chris D Platsoucas; Ralph S Freedman
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.
Clinical and experimental immunology 1998;112(2):172-80.
1998: A Vasuratna; Andrzej P Kudelka; Creighton L Edwards; V Wootipoom; Claire F Verschraegen; C Charnsangavej; John J Kavanagh
Prolonged remission of endometrial cancer with paclitaxel and carboplatin.
Anti-cancer drugs 1998;9(3):283-5.
1998: Bohuslav Melichar; Cherylyn A Savary; Andrzej P Kudelka; Claire F Verschraegen; John J Kavanagh; Creighton L Edwards; Chris D Platsoucas; Ralph S Freedman
Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):799-809.
1998: Claire F Verschraegen; E A Natelson; Beppino C Giovanella; John J Kavanagh; Andrzej P Kudelka; Ralph S Freedman; Creighton L Edwards; K Ende; John S Stehlin
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor.
Anti-cancer drugs 1998;9(1):36-44.
1997: G Ferrandina; Bohuslav Melichar; AE Loercher; Claire F Verschraegen; Andrzej P Kudelka; Creighton L Edwards; G Scambia; John J Kavanagh; James L Abbruzzese; Ralph S Freedman
Growth inhibitory effects of sodium phenylacetate (NSC 3039) on ovarian carcinoma cells in vitro.
Cancer research 1997;57(19):4309-15.
1997: Andrzej P Kudelka; T Levy; Claire F Verschraegen; Creighton L Edwards; S Piamsomboon; Wichai Termrungruanglert; Ralph S Freedman; Alan L Kaplan; Dirk G Kieback; Christina A Meyers; Kurt A Jaeckle; Evelyne M Loyer; Melissa Steger; RP Mante; Giora Mavligit; A Killian; R A Tang; Jordan U Gutterman; John J Kavanagh
A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(9):1501-5.
1997: Andrzej P Kudelka; Rodger Winn; Creighton L Edwards; G Downey; H Greenberg; Shaker R Dakhil; Ralph S Freedman; Salvatore J. LoCoco; J Umbreit; J E Delmore; Arbuck Susan; Evelyne M Loyer; P Gacrama; R Fueger; John J Kavanagh
An update of a phase II study of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
Anti-cancer drugs 1997;8(7):657-61.
1997: Andrzej P Kudelka; Zahid H Siddik; D Tresukosol; Creighton L Edwards; Ralph S Freedman; Timothy L Madden; R Rastogi; M Hord; E Edmund Kim; Carmen Tornos; RP Mante; John J Kavanagh
A phase II and pharmacokinetic study of enloplatin in patients with platinum refractory advanced ovarian carcinoma.
Anti-cancer drugs 1997;8(7):649-56.
1997: Koen van Besien; Claire F Verschraegen; R Mehra; Sergio Giralt; Andrzej P Kudelka; Creighton L Edwards; S Piamsonboom; Wichai Termrungruanglert; Richard Champlin; John J Kavanagh
Complete remission of refractory gestational trophoblastic disease with brain metastases treated with multicycle ifosfamide, carboplatin, and etoposide (ICE) and stem cell rescue.
Gynecologic oncology 1997;65(2):366-9.
1997: Wichai Termrungruanglert; Andrzej P Kudelka; Creighton L Edwards; L Delclos; Claire F Verschraegen; John J Kavanagh
Gynecologic cancer in the elderly.
Clinics in geriatric medicine 1997;13(2):363-79.
1997: Christina A Meyers; Andrzej P Kudelka; Charles A Conrad; C K Gelke; W Grove; Richard Pazdur
Neurotoxicity of CI-980, a novel mitotic inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):419-22.
1997: A A Ashour; Claire F Verschraegen; Andrzej P Kudelka; John J Kavanagh
Paraneoplastic syndromes of gynecologic neoplasms.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1272-82.
1997: Claire F Verschraegen; T Levy; Andrzej P Kudelka; E Llerena; K Ende; Ralph S Freedman; Creighton L Edwards; M Hord; Melissa Steger; Alan L Kaplan; Dirk G Kieback; Ami Fishman; John J Kavanagh
Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):625-31.
1997: S Piamsomboon; Andrzej P Kudelka; Wichai Termrungruanglert; Koen van Besien; Creighton L Edwards; S Lifshitz; D F Schomer; Richard Champlin; RP Mante; John J Kavanagh; Claire F Verschraegen
Remission of refractory gestational trophoblastic disease in the brain with ifosfamide, carboplatin, and etoposide (ICE): first report and review of literature.
European journal of gynaecological oncology 1997;18(6):453-6.
1997: Ozcan Balat; Andrzej P Kudelka; Creighton L Edwards; Claire F Verschraegen; John J Kavanagh
Prolonged remission of platinum-refractory ovarian cancer with docetaxel: brief report and review of literature.
European journal of gynaecological oncology 1997;18(5):341-2.
1997: Walter F Baile; Renato Lenzi; Andrzej P Kudelka; P Maguire; D Novack; M Goldstein; E G Myers; R C Bast
Improving physician-patient communication in cancer care: outcome of a workshop for oncologists.
Journal of cancer education : the official journal of the American Association for Cancer Education 1997;12(3):166-73.
1997: Wichai Termrungruanglert; Andrzej P Kudelka; S Piamsomboon; Creighton L Edwards; Carmen Tornos; John J Kavanagh
Prolonged oral etoposide for advanced uterine leiomyosarcoma with pulmonary metastases: case report.
European journal of gynaecological oncology 1997;18(2):97-100.
1997: Bryan Fisk; JM Hudson; John Kavanagh; J Taylor Wharton; James L Murray; Constantin G Ioannides; Andrzej P Kudelka
Existent proliferative responses of peripheral blood mononuclear cells from healthy donors and ovarian cancer patients to HER-2 peptides.
Anticancer research 1997;17(1A):45-53.
1997: J Herrada; Andrzej P Kudelka; Carmen Tornos; Dong M Shin; J J Kavanagh; Creighton L Edwards; Claire F Verschraegen
Remission with carboplatin of paclitaxel resistant primary peritoneal papillary serous carcinoma: case report.
European journal of gynaecological oncology 1997;18(1):39-41.
1997: E Llerena; Andrzej P Kudelka; Carmen Tornos; G F Cedillo; A Lopez; Creighton L Edwards; J P Litam; John J Kavanagh
Remission of a chemotherapy resistant tumor of low malignant potential with tamoxifen.
European journal of gynaecological oncology 1997;18(1):23-5.
1997: Bryan Fisk; BW Anderson; KR Gravitt; Catherine A O'Brian; Andrzej P Kudelka; James L Murray; J Taylor Wharton; Constantin G Ioannides
Identification of naturally processed human ovarian peptides recognized by tumor-associated CD8+ cytotoxic T lymphocytes.
Cancer research 1997;57(1):87-93.
1996: E G Hanania; R E Giles; John Kavanagh; SQ Fu; D Ellerson; Z Zu; T Wang; Y Su; Andrzej P Kudelka; Zia Rahman; Frankie A Holmes; Gabriel N Hortobagyi; David F Claxton; CR Bachier; Peter F Thall; S Cheng; Jeane Hester; J M Ostrove; R E Bird; A Chang; Martin Korbling; D Seong; Richard J Cote; Tatyana A Holzmayer; Albert Deisseroth
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15346-51.
1996: Ralph S Freedman; J A Gibbons; M Giedlin; Andrzej P Kudelka; John J Kavanagh; Creighton L Edwards; C H Carrasco; Michael A Nash; Chris D Platsoucas
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1996;19(6):443-51.
1996: Andrzej P Kudelka; Wichai Termrungruanglert; S Vadhan-Raj; Creighton L Edwards; D G Varma; Carmen Tornos; Claire F Verschraegen; John J Kavanagh
Remission of advanced uterine leiomyosarcoma with pulmonary metastases with carboplatin and paclitaxel.
Anti-cancer drugs 1996;7(8):885-9.
1996: V Wright-Browne; Andrzej P Kudelka; Anais Malpica; Creighton L Edwards; D G Varma; John J Kavanagh
Persistent partial molar pregnancy. A report of uterus-preserving treatment and follow-up with magnetic resonance imaging.
American journal of clinical oncology 1996;19(5):534-9.
1996: S Piamsomboon; Wichai Termrungruanglert; Andrzej P Kudelka; Creighton L Edwards; Ralph S Freedman; C F Mountain; L Delclos; M S Aapro; L DeCaro; J Bianca; Claire F Verschraegen; John J Kavanagh
Prolonged stabilization of progressive squamous cell cancer of the cervix with interferon-alpha and 13-cis-retinoic acid: report of two cases and review of the literature.
Anti-cancer drugs 1996;7(7):800-4.
1996: Andrzej P Kudelka; Rodger Winn; Creighton L Edwards; G Downey; H Greenberg; Shaker R Dakhil; Ralph S Freedman; Evelyne M Loyer; J Rusinkiewicz; P Gacrama; R Fueger; John J Kavanagh
Activity of paclitaxel in advanced or recurrent squamous cell cancer of the cervix.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(8):1285-8.
1996: Claire F Verschraegen; Andrzej P Kudelka; Wichai Termrungruanglert; C G de Leon; Creighton L Edwards; Ralph S Freedman; John J Kavanagh; S Vadhan-Raj
Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent disease.
European journal of cancer (Oxford, England : 1990) 1996;32A(9):1609-11.
1996: Wichai Termrungruanglert; Andrzej P Kudelka; S Piamsomboon; Claire F Verschraegen; Creighton L Edwards; S Lifshitz; R P Mante; John J Kavanagh
Remission of refractory gestational trophoblastic disease with high-dose paclitaxel.
Anti-cancer drugs 1996;7(5):503-6.
1996: Andrzej P Kudelka; Claire F Verschraegen; Tally Levy; Creighton L Edwards; Ami Fishman; Ralph S Freedman; A Kaplan; Dirk G Kieback; R Mante; K Ende; Melissa Steger; John J Kavanagh
Preliminary report of the activity of docetaxel in advanced or recurrent squamous cell cancer of the cervix.
Anti-cancer drugs 1996;7(4):398-401.
1996: Ami Fishman; Andrzej P Kudelka; Damras Tresukosol; Creighton L Edwards; Ralph S Freedman; A L Kaplan; R E Girtanner; John J Kavanagh
Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor.
The Journal of reproductive medicine 1996;41(6):393-6.
1996: John J Kavanagh; Andrzej P Kudelka; C G de Leon; Damras Tresukosol; M Hord; M B Finnegan; E Edmund Kim; D Varma; A Forman; P Cohen; Creighton L Edwards; Ralph S Freedman; Claire F Verschraegen
Phase II study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(5):837-42.
1996: Damras Tresukosol; Andrzej P Kudelka; Creighton L Edwards; E G Silva; M Kanojia; John J Kavanagh
Leuprolide acetate in advanced ovarian serous tumor of low malignant potential. A case report.
The Journal of reproductive medicine 1996;41(5):363-6.
1996: Andrzej P Kudelka; Damras Tresukosol; Creighton L Edwards; Ralph S Freedman; Charles Levenback; P Chantarawiroj; C Gonzalez de Leon; E Edmund Kim; Timothy Madden; B Wallin; M Hord; Claire F Verschraegen; Martin N Raber; John J Kavanagh
Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1552-7.
1996: Andrzej P Kudelka; Damras Tresukosol; C Gonzalez de Leon; Wichai Termrungruanglert; Creighton L Edwards; Ralph S Freedman; Carmen Tornos; John J Kavanagh
Paclitaxel in patients with platinum-resistant ovarian cancer: a selected review of literature and clinical experience.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 1996;79(4):240-5.
1996: Wichai Termrungruanglert; Andrzej P Kudelka; S Piamsomboon; Creighton L Edwards; Claire F Verschraegen; Evelyne M Loyer; John J Kavanagh
Remission of recurrent cervical cancer with paclitaxel and carboplatin: a case report and review of literature.
European journal of gynaecological oncology 1996;17(6):493-6.
1996: Y C Lin; Andrzej P Kudelka; D Lawrence; Claire F Verschraegen; John J Kavanagh; Creighton L Edwards; R Mante; Ralph S Freedman
Transcatheter arterial embolization for the control of life-threatening pelvic hemorrhage in a patient with locally advanced cervix carcinoma.
European journal of gynaecological oncology 1996;17(6):480-3.
1996: O Balat; Andrzej P Kudelka; Creighton L Edwards; Claire F Verschraegen; John J Kavanagh
Remission of recurrent mixed germ cell tumor of the ovary after treatment with vincristine, carboplatin, fluorouracil, and ifosfamide: a case report and review of the literature.
European journal of gynaecological oncology 1996;17(5):342-4.
1996: O Balat; Claire F Verschraegen; Creighton L Edwards; E Silva; Andrzej P Kudelka; John J Kavanagh
Unusual presentation of a metastatic choriocarcinoma following a full term pregnancy: a case report.
European journal of gynaecological oncology 1996;17(4):271-3.
1996: O Balat; Andrzej P Kudelka; J C Tunca; Creighton L Edwards; Claire F Verschraegen; John J Kavanagh
Prolonged stabilization of progressive platinum-refractory ovarian cancer with paclitaxel: brief report.
European journal of gynaecological oncology 1996;17(4):264-6.
1996: O Balat; Andrzej P Kudelka; Jae Y Ro; Creighton L Edwards; D Balbay; C Dinney; John J Kavanagh
Two synchronous primary tumors of the ovary and kidney: a case report.
European journal of gynaecological oncology 1996;17(4):257-9.
1996: O Balat; Andrzej P Kudelka; Creighton L Edwards; Claire F Verschraegen; R Mante; John J Kavanagh
A case report of paclitaxel administered to a patient with platinum-refractory ovarian cancer on long-term hemodialysis.
European journal of gynaecological oncology 1996;17(3):232-3.
1996: Damras Tresukosol; Andrzej P Kudelka; C Gonzales de Leon; Creighton L Edwards; Ralph S Freedman; R Mante; M Hord; John J Kavanagh
Paclitaxel retreatment in patients with platinum and paclitaxel resistant ovarian cancer.
European journal of gynaecological oncology 1996;17(3):188-91.
1996: O Balat; Andrzej P Kudelka; Creighton L Edwards; E Silva; John J Kavanagh
Malignant transformation in endometriosis of the urinary bladder: case report of clear cell adenocarcinoma.
European journal of gynaecological oncology 1996;17(1):13-6.
1995: J A Romero; E Edmund Kim; Damras Tresukosol; Andrzej P Kudelka; Creighton L Edwards; John J Kavanagh
Recurrent ovarian endodermal sinus tumor: demonstration by computed tomography, magnetic resonance imaging, and positron emission tomography.
European journal of nuclear medicine 1995;22(10):1214-7.
1995: Damras Tresukosol; Andrzej P Kudelka; Anais Malpica; D G Varma; Creighton L Edwards; John J Kavanagh
Leuprolide acetate and intravascular leiomyomatosis.
Obstetrics and gynecology 1995;86(4 Pt 2):688-92.
1995: Andrzej P Kudelka; Z M Siddik; O Balat; John J Kavanagh
Carboplatin dosimetry in renal failure.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):2147-8.
1995: Y C Lin; Andrzej P Kudelka; Damras Tresukosol; Anais Malpica; C H Carrasco; DD Lawrence; R E Collier; A Munoz; L Delclos; John J Kavanagh
Prolonged stabilization of progressive endometrial stromal sarcoma with prolonged oral etoposide therapy.
Gynecologic oncology 1995;58(2):262-5.
1995: Damras Tresukosol; Andrzej P Kudelka; Creighton L Edwards; G L Fromm; R Mante; John J Kavanagh
Primary fallopian tube adenocarcinoma: clinical complete response after salvage treatment with high-dose paclitaxel.
Gynecologic oncology 1995;58(2):258-61.
1995: P Chantarawiroj; Damras Tresukosol; Andrzej P Kudelka; Creighton L Edwards; E G Silva; J T Wharton; John J Kavanagh
Prolonged oral etoposide for refractory advanced uterine leiomyosarcoma.
Gynecologic oncology 1995;58(2):248-50.
1995: John Kavanagh; Damras Tresukosol; C Edwards; R Freedman; C Gonzalez de Leon; Ami Fishman; R Mante; M Hord; Andrzej P Kudelka
Carboplatin reinduction after taxane in patients with platinum-refractory epithelial ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1584-8.
1995: R Vassilopoulou-Sellin; Andrzej P Kudelka; John J Kavanagh; Creighton L Edwards; S Vadhan-Raj
Effects of interleukin-1 alpha administration on pituitary-adrenal and pituitary-thyroid axes function of patients with ovarian cancer.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;17(2):109-13.
1995: S Wilailak; Andrzej P Kudelka; L R Donner; E Silva; R Mante; John J Kavanagh
Peritoneal papillary serous carcinoma: response to Taxol in platinum resistant disease.
European journal of gynaecological oncology 1995;16(3):187-9.
1994: Ralph S Freedman; Creighton L Edwards; John J Kavanagh; Andrzej P Kudelka; Ruth Katz; C H Carrasco; E Neely Atkinson; W Scott; B Tomasovic; S Templin
Intraperitoneal adoptive immunotherapy of ovarian carcinoma with tumor-infiltrating lymphocytes and low-dose recombinant interleukin-2: a pilot trial.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(3):198-210.
1994: J A Romero; E Edmund Kim; Andrzej P Kudelka; Creighton L Edwards; John J Kavanagh
MRI of recurrent cystic mesothelioma: differential diagnosis of cystic pelvic masses.
Gynecologic oncology 1994;54(3):377-80.
1994: Saroj Vadhan-Raj; Nicholas E Papadopoulos; Michael A Burgess; K A Linke; Shreyaskumar R Patel; C Hays; A Arcenas; Carl Plager; Andrzej P Kudelka; Walter N Hittelman
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):715-24.
1994: Saroj Vadhan-Raj; Andrzej P Kudelka; L Garrison; Jacalyn B Gano; Creighton L Edwards; Ralph S Freedman; John J Kavanagh
Effects of interleukin-1 alpha on carboplatin-induced thrombocytopenia in patients with recurrent ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):707-14.
1994: Ralph S Freedman; B Tomasovic; S Templin; E Neely Atkinson; Andrzej P Kudelka; Creighton L Edwards; Chris D Platsoucas
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy.
Journal of immunological methods 1994;167(1-2):145-60.
1993: John J Kavanagh; Andrzej P Kudelka
Systemic therapy for gynecologic cancer.
Current opinion in oncology 1993;5(5):891-9.
1993: I R Kirk; C H Carrasco; DD Lawrence; V P Chuang; W R Richli; Chusilp Charnsangavej; John J Kavanagh; Andrzej P Kudelka; R S Freedman; A B Markowitz
Intraperitoneal catheters: percutaneous placement with fluoroscopic guidance.
Journal of vascular and interventional radiology : JVIR 1993;4(2):299-304.